Immune abnormalities induced by human endogenous retroviral peptides: With reference to the pathogenesis of systemic lupus erythematosus

Journal of Clinical Immunology

Volumn 23, Issue 5, 2003, Pages 371-376

  Naito, Toshio ^a   Ogasawara, Hitoshi ^a   Kaneko, Hiroshi ^a   Hishikawa, Takashi ^a   Sekigawa, Iwao ^b   Hashimoto, Hiroshi ^a   Maruyama, Naoki ^c  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Human endogenous retrovirus; Interleukin 16; Systemic lupus erythematosus; T cell activation; T cell anergy

Indexed keywords

INTERLEUKIN 16; INTERLEUKIN 6; MEMBRANE PROTEIN; SYNTHETIC PEPTIDE; VIRUS PROTEIN;

ARTICLE; CLONAL ANERGY; CLONE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENVELOPE GENE; GENE SEQUENCE; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN ENDOGENOUS RETROVIRUS; IMMUNOPATHOLOGY; MOLECULAR CLONING; MONONUCLEAR CELL; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; RETROVIRUS; SEQUENCE HOMOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

CELLS, CULTURED; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-16; INTERLEUKIN-2; LUPUS ERYTHEMATOSUS, SYSTEMIC; PEPTIDES; RETROVIRIDAE PROTEINS;

EID: 0041330422     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025369500466     Document Type: Article

References (31)

1. Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, Okumura K, Kaneko Y: Role of Tumor necrosis factor-alpha (TNF-α) in the induction of HIV-1 gp120-mediated CD4+ T cell anergy. Clin Exp Immunol 109:41-46, 1997
2. Sekigawa I, Kaneko H, Hishikawa T, Hashimoto H, Hirose S, Kaneko Y, Maruyama N: HIV infection and SLE: Their pathogenic relationship. Clin Exp Rheumatol 16:175-180, 1998
3. Cianciolo GJ, Copeland TD, Oroszlan S, Synderman R: Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230:453-455, 1985
4. Harris DT, Cianciolo GJ, Snyderman R, Argov S, Koren HS: Inhibition of human natural killer cell activation by a synthetic peptide homologous to a conserved region in the retroviral protein, p 15E. J Immunol 138:889-894, 1987
5. Ruegg CL, Monell CR, Strand M: Inhibition of lymphoproliferation by synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J Virol 63:3257-3260, 1989
6. Haraguchi S, Good RA, Cianciolo GJ, Engelman RW, Day NK: Immunosuppressive retroviral peptides: Immunopathological implications for immunosuppressive influences of retroviral infections. J Leukoc Biol 61:654-666, 1997
7. Hishikawa T, Kaneko H, Shirasawa T, Matsuura Y, Sekigawa I, Takasaki Y, Hashimoto H, Hirose S, Handa S, Nagasawa R, Maruyama N: Detection of antibodies to recombinant gag protein derived from human endogenous retrovirus like sequence, clone 4-1, in autoimmune diseases. Viral Immunol 10:137-147, 1997
8. Ogasawara H, Kaneko H, Hishikawa T, Sekigawa I, Takasaki Y, Hashimoto H, Hirose S, Kaneko Y, Maruyama N: Molecular mimicry between human endogenous retrovirus clone 4-1 and HLA class I antigen: With reference to the pathogenesis of systemic lupus erythematosus. Rheumatology 38:1163-1164, 1999
9. Ogasawara H, Hishikawa T, Sekigawa I, Hashimoto H, Yamamoto N, Maruyama M: Sequence analysis of human endogenous retrovirus clone 4-1 in systemic lupus erythematosus. Autoimmunity 33:15-21, 2001
10. Ogasawara H, Naito T, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, Kaneko Y, Yamamoto N, Maruyama N, Yamamoto N: Quantitative analyses of messenger RNA of human endogenous retrovirus in SLE patients. J Rheumatol 28:533-538, 2001
11. Sekigawa I, Ogasawara H, Kaneko H, Hishikawa T, Hashimoto H: Retroviruses and autoimmunity. Intern Med 40:80-86, 2001
12. Ogasawara H, Okada M, Kaneko H, Hishikawa T, Sekigawa I, Iida N, Maruyama N, Yamamoto N, Hashimoto H: Quantitative comparison of human endogenous retrovirus mRNA between SLE and rheumatoid arthritis. Lupus 10:517-518, 2001
13. Okada M, Ogasawara H, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, Maruyama N, Kaneko K, Yamamoto N: Role of DNA methylation in the transcription of human endogenous retrovirus: With reference to the pathogenesis of SLE. J Rheumatol 29:1678-1682, 2002
14. Horwitz DA, Stohl W, Gray JD: T lymphocytes, natural killer cells, cytokines, and immune regulation. In Dubois, Lupus Erythematosus, DJ Wallance, BH Harn (eds). Baltimore, Williams & Wilkins, 1997, pp 155-194
15. Center DM, Kornfeld H, Cruikshank WW: Interleukin 16 and its function as a CD4 ligand. Immunol Today 17:476-481, 1996
16. Lee S, Kaneko H, Sekigawa I, Tokano Y, Takasaki Y, Hashimoto H: Circulating interleukin-16 in systemic lupus erythematosus. Br J Rheumatol 37:1334-1337, 1998
17. Lard LR, Roep BO, Verburgh CA, Zwinderman AH, Huizinga TWJ: Elevated IL-16 levels in patients with systemic lupus erythematosus are associated with disease severity but not with genetic susceptibility to lupus. Lupus 11:181-185, 2002
18. Ogasawara H, Takeda-Hirokawa N, Sekigawa I, Hashimoto H, Kaneko Y, Hirose S: Inhibitory effect of interleukin-16 in interleukin-2 production by CD4+ T cells. Immunology 96:215-219, 1999
19. Sekigawa I, Matsushita M, Lee S, Maeda N, Ogasawara H, Kaneko H, Iida N, Hashimoto H: A possible pathogenic role of CD8+ T cells and their derived cytokine, IL-16, in SLE. Autoimmunity 33:37-44, 2001
20. Chirmule N, Oyaizu N, Saxinger C, Pahwa S: Nef protein of HIV-1 has B-cell stimulatory activity. AIDS 8:733-739, 1994
21. Repaske R, Stoele PE, O'Neill RR, Rabson AB, Martin MA: Nucleotide sequence of a full-length human endogenous retroviral segment. J Virol 54:764-772, 1985
22. Hishikawa T, Tokano Y, Sekigawa I, Ando S, Takasaki Y, Hashimoto H, Hirose S, Okumura K, Abe M, Shirai T: HLA-DP+ T cells and deficient interleukin-2 production in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 55:285-296, 1990
23. Kalden JR, Gay S: Retroviruses and autoimmune rheumatic disease. Clin Exp Immunol 98:1-5, 1994
24. Herrmann M, Hagenhofer M, Kalden JR: Retrovirus and systemic lupus erythematosus. Immunol Rev 152:145-156, 1996
25. Nakagawa K, Harrison LC: The potential roles of endogenous retroviruses in autoimmunity. Immunol Rev 152:193-236, 1996
26. Portis JL: Perspectives on the role of endogenous human retroviruses in autoimmune diseases. Virology 296:1-5, 2002
27. Maeda N, Sekigawa I, Iida N, Matsumoto M, Hashimoto H, Hirose S: Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus. Scand J Rheumatol 28:166-170, 1999
28. Matsushita M, Hayashi T, Ando S, Sekigawa I, Iida N, Hashimoto H, Hirose S: Changes of CD4+/CD8+ T cell ratio and IL-16 levels on treatment in SLE patients. Clin Rheumatol 19:270-274, 2000
29. Linker-Israeli M, Gray JD, Quismorio FP, Jr, Horwitz DA: Characterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosus. Clin Exp Immunol 73:236-241, 1988
30. Linker-Israeli M, Quismorio FP, Jr, Horwitz DA: Further characterization of interleukin-2 production by lymphocytes of patients with systemic lupus erythematosus. J Rheumatol 15:1216-1222, 1988
31. Rammensee HG, Friede T, Stevanoviiv S: MHC ligands and peptide motifs: First listing. Immunogenetics 41:178-228, 1995